Reported escape mechanisms to BCL-2 inhibition in AML are increased fatty acid oxidation that replaced BCAAs as a TCA cycle fuel and nicotinamide metabolism which supplies the TCA cycle with NAD+.95 This evidence concerns the gene BCL2 and acute myeloid leukemia.